There are 449 resources available
52P - Liquid biopsy monitoring in BRAF V600E mutated NSCLC patients treated with dabrafenib plus trametinib: A prospective, explorative, multicentric study, LiBRA study (GOIRC-03-2020)
Presenter: Alessandro Leonetti
Session: Poster Display session
53P - MET exon 14 skipping mutations in non-small cell lung cancer: Real-world data from the Italian biomarker ATLAS database
Presenter: Maria Lucia Reale
Session: Poster Display session
54P - Efficacy of first-line immunotherapy for non-small cell lung cancer with MET exon 14 skipping according to PD-L1 expression
Presenter: Miriam Blasi
Session: Poster Display session
55P - Differences in response to immune treatment between KRAS G12C and KRAS non-G12C mutated non-small cell lung cancer
Presenter: Laura Pinto
Session: Poster Display session
56P - Prevalence, clinical characteristics, and treatment outcomes of patients with KRAS-mutated non-squamous NSCLC and PD-L1 expression: Real-life data analysis
Presenter: Jana Safrankova
Session: Poster Display session
57P - Retrospective comparative analysis of KRAS mutations in mNSCLC patients treated with first-line immunotherapy or chemoimmunotherapy
Presenter: Sabrina Rossi
Session: Poster Display session
58P - Molecular characteristics and prognostic value of homologous recombination deficiency (HRD) in non-small cell lung cancer patients
Presenter: Zheng Wang
Session: Poster Display session
59P - Datopotamab deruxtecan (Dato-DXd) in patients with previously treated advanced non-small cell lung cancer (NSCLC): Nonsquamous (NSQ) histology in the phase III TROPION-Lung01 trial
Presenter: Nicolas Girard
Session: Poster Display session
60P - Sacituzumab govitecan (SG) + pembrolizumab (pembro) in first-line (1L) metastatic non-small cell lung cancer (mNSCLC): Efficacy results by histology from the EVOKE-02 study
Presenter: Federico Cappuzzo
Session: Poster Display session
61P - First-line camrelizumab (Camre) plus carboplatin (Carbo) and pemetrexed (Pem) for advanced non-squamous NSCLC: 5-yr outcomes of CameL phase III study
Presenter: Caicun Zhou
Session: Poster Display session